Viral Inactivation
Viral Inactivation is a bioprocess intervention that belongs to the class of viral clearance strategies, specifically defined by the deliberate disruption of viral infectivity through chemical or physical means while preserving the integrity of the biopharmaceutical product in continuous biomanufacturing systems.
661
Publications
30.8K
Citations
3K
Authors
873
Institutions
Publications per year
2017–2026
149
661
Erwin Duizer, Paul Bijkerk, Barry Rockx et al. · Applied and Environmental Microbiology · 2004 · 403 citations · Full text
1–5 of 661
3K
11
h-index
9
h-index
5
h-index
5
h-index
5
h-index
1–5 of 3K
873
National Institutes of Health
Bethesda, United States
18 h-index
55 publications
4K citations
American Red Cross
Washington, United States
10 h-index
18 publications
453 citations
Center for Biologics Evaluation and Research
Silver Spring, United States
9 h-index
26 publications
2K citations
National Institute of Allergy and Infectious Diseases
Bethesda, United States
9 h-index
31 publications
2.2K citations
Bayer (United States)
Whippany, United States
8 h-index
40 publications
1.6K citations
Baxter (Austria)
Vienna, Austria
8 h-index
38 publications
2.1K citations
Yale University
New Haven, United States
7 h-index
9 publications
308 citations

Johns Hopkins University
Baltimore, United States
7 h-index
20 publications
732 citations
1–8 of 873
AEM · 30 publications · 2.2K citations
24
h-index
31 publications · 1.7K citations
21
h-index
22 publications · 828 citations
17
h-index
19 publications · 540 citations
17
h-index
Repository · 33 publications · 721 citations
16
h-index
1–5